Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13,075 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Enhancement by ascorbic acid 2-glucoside or repeated additions of ascorbate of mitogen-induced IgM and IgG productions by human peripheral blood lymphocytes.
Tanaka M, Muto N, Gohda E, Yamamoto I. Tanaka M, et al. Jpn J Pharmacol. 1994 Dec;66(4):451-6. doi: 10.1254/jjp.66.451. Jpn J Pharmacol. 1994. PMID: 7723222
The pharmacokinetics and pharmacodynamics of a new thromboxane synthetase inhibitor, 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid (DP-1904) in man after repeated oral doses.
Tanaka M, Ono K, Hakusui H, Takegoshi T, Shiozawa T, Suzuki T, Nii S, Shibata H. Tanaka M, et al. J Pharm Pharmacol. 1990 Jul;42(7):491-5. doi: 10.1111/j.2042-7158.1990.tb06602.x. J Pharm Pharmacol. 1990. PMID: 1980290
Effects of chronic treatment with carvedilol on abnormalities of endothelium-dependent relaxation and structure of endothelium in resistance arteries of SHRSP.
Sasaki F, Yamamoto K, Shimamura K, Shibutani T, Hashimoto H, Tanaka M, Sunano S. Sasaki F, et al. Among authors: tanaka m. Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S329-30. doi: 10.1111/j.1440-1681.1995.tb02940.x. Clin Exp Pharmacol Physiol Suppl. 1995. PMID: 9072414
AT1 receptor-mediated stimulation by angiotensin II of rat aortic fibronectin gene expression in vivo.
Kim S, Ohta K, Hamaguchi A, Omura T, Tominaga K, Yukimura T, Miura K, Tanaka M, Iwao H. Kim S, et al. Among authors: tanaka m. Br J Pharmacol. 1994 Nov;113(3):662-3. doi: 10.1111/j.1476-5381.1994.tb17042.x. Br J Pharmacol. 1994. PMID: 7858853 Free PMC article.
Pharmacologic profiles of GA0113, a novel quinoline derivative angiotensin II AT1-receptor antagonist.
Ebisu H, Nishikawa M, Tanaka M, Okazoe T, Morizawa Y, Shinyama H, Nakamura N. Ebisu H, et al. Among authors: tanaka m. J Cardiovasc Pharmacol. 1999 Oct;34(4):526-32. doi: 10.1097/00005344-199910000-00008. J Cardiovasc Pharmacol. 1999. PMID: 10511127
Serum antibody production by oral immunization with dextran B512.
Tanaka M, Takeda Y, Takeo S. Tanaka M, et al. J Immunol Methods. 1993 Feb 26;159(1-2):245-51. doi: 10.1016/0022-1759(93)90163-2. J Immunol Methods. 1993. PMID: 7680367
Enhancement of in vitro antibody production of murine splenocytes by ascorbic acid 2-O-alpha-glucoside.
Yamamoto I, Tanaka M, Muto N. Yamamoto I, et al. Among authors: tanaka m. Int J Immunopharmacol. 1993 Apr;15(3):319-25. doi: 10.1016/0192-0561(93)90042-w. Int J Immunopharmacol. 1993. PMID: 8505144
Augmentation of mitogen-induced interleukin 2 production by oral administration of polysaccharide SPR-901.
Tanaka M, Miyazaki H, Takeda Y, Takeo S, Yoshikai Y, Nomoto K. Tanaka M, et al. Immunopharmacol Immunotoxicol. 1992;14(3):403-20. doi: 10.3109/08923979209005401. Immunopharmacol Immunotoxicol. 1992. PMID: 1517528
Mechanisms of action of OPC-28326, a selective hindlimb vasodilator.
Orito K, Imaizumi T, Yoshida K, Fujiki H, Kishi M, Teramoto S, Tanaka M, Shimizu H, Tominaga M, Kimura Y, Kambayashi J, Mori T. Orito K, et al. Among authors: tanaka m. J Pharmacol Exp Ther. 1999 Nov;291(2):604-11. J Pharmacol Exp Ther. 1999. PMID: 10525078
Antiscorbutic activity of L-ascorbic acid 2-glucoside and its availability as a vitamin C supplement in normal rats and guinea pigs.
Yamamoto I, Suga S, Mitoh Y, Tanaka M, Muto N. Yamamoto I, et al. Among authors: tanaka m. J Pharmacobiodyn. 1990 Nov;13(11):688-95. doi: 10.1248/bpb1978.13.688. J Pharmacobiodyn. 1990. PMID: 2093127
13,075 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page